Johnson Matthey manufactures a comprehensive range of biocatalysts to support the development of pharmaceuticals, agrochemicals, and other fine chemicals from initial screening to commercial-scale supply. Our enzyme portfolio complements our chemo-catalyst technology, providing a versatile and effective approach to synthesizing key chiral intermediates.
In addition to our commercial enzymes, we also customize them for your specific application. Our biocatalysis expertise ensures an optimized and scalable process for the production of chiral compounds.
Advantages of JM biocatalyst portfolio
Diversity
Unlock maximum enzyme diversity with our novel wildtypes, cherry-picked mutants, and in silico-designed variants. Selected for their unique substrate scopes.
Ready-to-use
Our process expertise and 10 years of R&D have been used to validate and optimize our enzyme collection. Our enzymes are fit for purpose and ready to perform in demanding environments.
Available at scale
We specialise in scaling enzyme production from kits to large-volume. Our experts collaborate to optimise processes and address the challenges of scaling up.
